NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap Up to $16.75 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
NewAmsterdam Pharma (NASDAQ:NAMSW – Get Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 35,200 shares, an increase of 13.5% from the November 15th total of 31,000 shares. Based on an average trading volume of 8,300 shares, the […]
NewAmsterdam Pharma (NASDAQ:NAMSW – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 35,200 shares, a growth of 13.5% from the November 15th total of 31,000 shares. Based on an average trading volume of 8,300 shares, the […]
By Colin Kellaher NewAmsterdam Pharma has hired Ian Somaiya as chief financial officer of the clinical-stage biopharmaceutical company. The Netherlands-based.